Monocytes and the recruitment of monocyte-derived macrophages into sites of inflammation play a key role in atherogenesis and other chronic inflammatory diseases linked to cardiometabolic syndrome and obesity. Previous studies from our group have shown that metabolic stress promotes monocyte priming, i.e. enhanced adhesion and accelerated chemotaxis of monocytes in response to chemokines, both in vitro and in dyslipidemic LDLR-/- mice. We also showed that metabolic stress-induced monocyte dysfunction is, at least to a large extent caused by the S-glutathionylation, inactivation, and subsequent degradation of MKP-1. Here, we analyzed the effects of a Western-style, dyslipidemic diet, which was composed of high levels of saturated fat, cholesterol, and simple sugars, on monocyte (dys)function in non-human primates (NHP). We found that similar to mice, a dyslipidemic diet enhances monocyte chemotaxis in NHP within four weeks, occurring concordantly with the onset of hypercholesterolemia but prior to changes in triglycerides, blood glucose, monocytosis or changes in monocyte subset composition. In addition, we identified transitory decreases in the acetylation of histone H3 at the lysine residues 18 and 23 in metabolically primed monocytes, and we found that monocyte priming was correlated with the acetylation of histone H3 at lysine 27 after an eight-week dyslipidemic diet regimen. Our data show that metabolic stress promotes monocyte priming and hyper-chemotactic responses in NHP. The histone modifications accompanying monocyte priming in primates suggest a reprogramming of the epigenetic landscape, which may lead to dysregulated responses and functionalities in macrophages derived from primed monocytes that are recruited to sites of inflammation
1 September 2025 in Journal of Pharmacy & Pharmacognosy Research
Context: The role of clinical pharmacists in a multidisciplinary team (MDT) related to pain management is still limited in Vietnamese hospitals. Aims: To evaluate the impact of clinical pharmacists within a multidisciplinary team (MDT) on postoperative pain management, focusing on the optimization of analgesic usage, drug safety, fentanyl consumption, and pain scores. Methods: Conducted at a tertiary hospital in Vietnam, this before-and-after study involved lumbar spine surgery patients. The intervention group received pharmacist-led MDT care, focusing on adherence to clinical pathways, minimizing adverse drug reactions (ADRs), and managing fentanyl use and pain levels using the Verbal Analogue Scale (VAS). Results: Eighty patients participated, split evenly between intervention and control groups. The intervention group showed significant improvements in analgesic compliance (97.5% vs. 80.0%, p=0.04) and a higher usage of nefopam over gabapentinoids. Although reductions in fentanyl dose and pain scores were observed, these changes were not statistically significant. Conclusions: Clinical pharmacists effectively enhanced pain management and drug safety within the MDT framework. Further research is necessary to more definitively ascertain the impact on pain scores.